Apotea (APOTEA)
Stockholm Exchange · Sweden · prices in SEK · close of 19 Oct 2026
Key indicators
| Last close | SEK 90.00 |
|---|---|
| 52-week range | 54.00 – 93.96 |
| Return, 1 month / 3 months | +12.5% / +23.0% |
| Return, 1 year / 3 years | −0.1% / – |
| Trend | Uptrend |
| RSI (14) | 72 |
| Volatility (1 year) | 41.1% |
| Worst drawdown (1 year) | -41.2% |
| Average daily value traded | 13.96M SEK |
| Dividend yield | 0.7% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Apotea is an online pharmacy based in Sweden that serves customers across the country through its website. It offers prescription medicines alongside over-the-counter drugs, health and beauty products, vitamins, and supplies for pets and households. Orders are handled through the company's own automated warehouse and distribution operation, which packs and ships goods directly to consumers. Its customers are mainly private individuals who prefer to shop for pharmacy and everyday health products online rather than in physical stores.
The shares are listed on the Stockholm Exchange in Sweden under the code APOTEA, and the price on this page is in Swedish kronor (SEK). Our dividend records, which start in 2019, show payments in one calendar year. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Apotea (APOTEA) trades on the Stockholm Exchange in Sweden. It last closed at SEK 90.00 on 19 October 2026.
Its price-based Market X-Ray is 68 out of 100 (a fair price profile), ranking 223 of 911 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 0.1% and over the last three months it rose 23.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Stockholm Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 89 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 25.4% | ||
| From 52-week high | -4.1% | ||
| Momentum | 76 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 23.0% | ||
| 6-month return | 32.6% | ||
| 12-month return, skipping the last month | -11.2% | ||
| Stability (higher is calmer) | 55 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 41.1% | ||
| Worst drawdown, 1 year (smaller is calmer) | -41.2% | ||
| Liquidity | 82 · Strong | Trades actively. | |
| Average daily value traded | 13.96M SEK | ||
| Zero-volume days | 0.0% | ||
| Income | 4 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.7% | ||
| Years with dividends | 1 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | +5.0% |
|---|---|
| 1 month | +12.5% |
| 3 months | +23.0% |
| 6 months | +32.6% |
| 1 year | −0.1% |
| 3 years | – |
| 5 years | – |
Signals
| 50-day / 200-day average | 79.32 / 71.78 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 2.05 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 27 May 2026 | SEK 0.6000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Stockholm Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.